APOE4 is both an important risk factor for late onset AD and lower brain glucose metabolism is present in AD-vulnerable brain regions in cognitively normal middle-aged carriers of APOE4 (Reiman et al., 2001). This evidence concerns the gene APOE and Alzheimer disease.